Status: current, Defined. Date: 30-Apr 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3081361000168113 | Midazolam (WP) (midazolam 5 mg / 1 mL) injection, 1 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3081371000168119 | Midazolam (WP) 5 mg/mL injection, ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Midazolam (WP) 5 mg/mL injection, ampoule | Is a | Midazolam (WP) | true | Inferred relationship | Some | ||
| Midazolam (WP) 5 mg/mL injection, ampoule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Midazolam (WP) 5 mg/mL injection, ampoule | Is a | midazolam 5 mg/mL injection, ampoule | true | Inferred relationship | Some | ||
| Midazolam (WP) 5 mg/mL injection, ampoule | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Midazolam (WP) 5 mg/mL injection, ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 1845051405 | |
| Midazolam (WP) 5 mg/mL injection, ampoule | has intended active ingredient | midazolam | true | Inferred relationship | Some | 1845051404 | |
| Midazolam (WP) 5 mg/mL injection, ampoule | has Australian BoSS | midazolam | true | Inferred relationship | Some | 1845051404 | |
| Midazolam (WP) 5 mg/mL injection, ampoule | has manufactured dose form | injection | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Midazolam (WP) 5 mg/mL injection, 1 mL ampoule | has TPUU | True | Midazolam (WP) 5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
| Midazolam (WP) (midazolam 5 mg / 1 mL) injection, 1 x 1 mL ampoule (containered trade product pack) | has TPUU | True | Midazolam (WP) 5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
| Midazolam (WP) 5 mg/mL injection, 5 x 1 mL ampoules | has TPUU | True | Midazolam (WP) 5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
| Midazolam (WP) (midazolam 5 mg / 1 mL) injection, 5 x 1 mL ampoules (trade product pack) | has TPUU | True | Midazolam (WP) 5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
| Midazolam (WP) 5 mg/mL injection, 10 x 1 mL ampoules | has TPUU | True | Midazolam (WP) 5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
| Midazolam (WP) 5 mg/mL injection, 10 x 1 mL ampoules | has TPUU | True | Midazolam (WP) 5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
Reference Sets
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
New South Wales Reportable Schedule 4 medications reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Western Australia Health Schedule 4 restricted medicines for public hospitals reference set
Trade product unit of use reference set
FHIR